CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-04 | Chambers Michael Andrew Director | Grant or award | +16,875 | 27,535 | ||
| 2025-12-18 | Chambers Michael Andrew Director | Returned to the company · Convertible Senior Notes | −0 | |||
| 2025-12-18 | Chambers Michael Andrew Director | Grant or award · Convertible Senior Notes | +0 | |||
| 2025-03-10 | Chambers Michael Andrew Director | Grant or award | +2,383 | 10,660 | ||
| 2025-03-10 | Chambers Michael Andrew Director | Grant or award · Stock Options (right to buy) | +4,792 | 4,792 | ||
| 2024-08-16 | Chambers Michael Andrew Director | Purchase | +13,106 | $133.07 | $1.7M | 260,102 |
| 2024-08-16 | Chambers Michael Andrew Director | Purchase | +18,284 | $134.06 | $2.5M | 278,386 |
| 2024-08-16 | Chambers Michael Andrew Director | Purchase | +5,648 | $134.66 | $761K | 284,034 |
| 2024-03-01 | Chambers Michael Andrew Director | Grant or award | +1,846 | 8,277 | ||
| 2024-03-01 | Chambers Michael Andrew Director | Grant or award · Stock Option (right to buy) | +3,679 | 3,679 | ||
| 2023-08-14 | Chambers Michael Andrew Director | Purchase | +5,947 | $109.19 | $649K | 242,964 |
| 2023-08-14 | Chambers Michael Andrew Director | Purchase | +4,032 | $109.89 | $443K | 246,996 |
| 2023-08-11 | Chambers Michael Andrew Director | Purchase | +23,686 | $108.05 | $2.6M | 237,017 |
| 2023-08-10 | Chambers Michael Andrew Director | Purchase | +2,206 | $104.67 | $231K | 180,670 |
| 2023-08-10 | Chambers Michael Andrew Director | Purchase | +1,091 | $105.90 | $116K | 181,761 |
| 2023-08-10 | Chambers Michael Andrew Director | Purchase | +31,570 | $106.26 | $3.4M | 213,331 |
| 2023-03-06 | Chambers Michael Andrew Director | Grant or award | +1,523 | 6,431 | ||
| 2023-03-06 | Chambers Michael Andrew Director | Grant or award · Stock Option (right to buy) | +3,257 | 3,257 | ||
| 2022-09-14 | Chambers Michael Andrew Director | Purchase | +20,744 | $103.87 | $2.2M | 71,822 |
| 2022-09-14 | Chambers Michael Andrew Director | Purchase | +30,106 | $104.67 | $3.2M | 101,928 |
Page 1 of 2 · 26 trades